ETFidea’s iShares Biotechnology ETF IBB Stock Holding History

ETFidea’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.61M	Buy	24,764 +67	+0.3%	+$9.69K	1.14%	21
2024 Q2	$3.39M	Sell	24,697 -48	-0.2%	-$6.41K	1.15%	21
2024 Q1	$3.4M	Buy	24,745 +339	+1%	+$46.3K	1.16%	22
2023 Q4	$3.32M	Sell	24,406 -274	-1%	-$33.4K	1.25%	22
2023 Q3	$3.02M	Sell	24,680 -307	-1%	-$39K	1.28%	21
2023 Q2	$3.17M	Buy	24,987 +126	+0.5%	+$16.4K	1.3%	21
2023 Q1	$3.21M	Sell	24,861 -171	-0.7%	-$22.4K	1.4%	20
2022 Q4	$3.29M	Sell	25,032 -773	-3%	-$99.9K	1.52%	19
2022 Q3	$3.02M	Sell	25,805 -190	-0.7%	-$23.6K	1.56%	20
2022 Q2	$3.06M	Sell	25,995 -6,301	-20%	-$748K	1.53%	18
2022 Q1	$4.21M	Sell	32,296 -1,265	-4%	-$165K	1.82%	18
2021 Q4	$5.12M	Buy	+33,561	New	+$5.2M	2.06%	14

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ETFidea's IBB Position: Q3 2024 in Review

ETFidea increased its iShares Biotechnology ETF (IBB) stake by 0.27% in Q3 2024, buying an estimated $9.69K and bringing the position to 24,764 shares worth $3.61M. The position accounts for 1.14% of the portfolio, ranked #21.

ETFidea first reported a position in IBB in Q4 2021 and has held it in 12 quarters since. The position peaked at $5.12M in Q4 2021. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

ETFidea held 24,764 shares of iShares Biotechnology ETF worth $3.61M as of Q3 2024.
ETFidea bought 67 iShares Biotechnology ETF shares in Q3 2024, an estimated $9.69K.
iShares Biotechnology ETF made up 1.14% of ETFidea's portfolio in Q3 2024, its #21 holding.
ETFidea first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 12 quarters since.
ETFidea's iShares Biotechnology ETF position peaked at $5.12M in Q4 2021.
893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on ETFidea's 13F filing for Q3 2024, filed 8 Nov 2024.